www.fdanews.com/articles/179031-fda-implements-broad-label-change-adding-warning-for-all-testosterone-products
![](https://www.fdanews.com/ext/resources/test/Drug-Images/Pharma-Labels.gif?t=1433873566&width=430)
FDA Implements Broad Label Change, Adding Warning for All Testosterone Products
October 26, 2016
The FDA is requiring a broad new warning to all labels for prescription testosterone products on the risks associated with abuse of anabolic androgenic steroids.
Prescription testosterone products are only approved by FDA as a hormone replacement therapy for men who have low testosterone due to certain medical conditions, genetic problems or damage to the testicles from chemotherapy or infection.